Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in September 2025 are slightly decreased compared to June 2025 (-12.5%)
Under proper supervision, a medical professional can adjust your dose, stop treatment, or give appropriate medical intervention based on your individual needs to avoid side effects
Most diminish after 2 to 4 weeks at each dose level as your body adjusts
Tirzepatide (Mounjaro and Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even greater weight loss in clinical trials compared to semaglutide
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
US$ 27.69
US$ 23.03
US$ 29.41
US$ 22.73
